Extended Induction Chemotherapy Does Not Improve the Outcome for High-Risk Neuroblastoma Patients: Results of the Randomized Open-Label GPOH Trial NB2004-HR

Annals of Oncology - United Kingdom
doi 10.1016/j.annonc.2019.11.011

Related search